Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part II.
Conclusions: Tumor factors in addition to radiation treatment may contribute to secondary effects. Enhanced clinical optimization should evaluate radiobiological doses delivered to the tumor volume and surrounding normal ocular structures.
PMID: 30237818 [PubMed]
Source: Journal of Contemporary Brachytherapy - Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
More News: Brachytherapy | Brain | Cataracts | Databases & Libraries | Eye Cancers | Eyes | Glaucoma | Iodine | Melanoma | Neurology | Skin Cancer | Statistics | Uveal Melanoma | Vitamin A